跳至主要内容
临床试验/2025-523374-17-01
2025-523374-17-01撤回4 期

Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the treatments with GLP-1RA and SGLT2i

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月23日最近更新:

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
60
试验地点
1
主要终点
Myocardium insulin resistance

研究概览

简要总结

To determine by means of 18F-FDG PET/CT and 99mTc-Tetrofosmin SPECT whether myocardial IR affects cardiac function and coronary flow and is therefore a risk factor for cardiovascular events and diabetic cardiomyopathy in DM2 patients with myocardial IR phenotype

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • BMI around 30 kg/m2
  • no-smoking; no-alcohol
  • HbA1c between 7-9%

排除标准

  • previous CVD events
  • hepatic and kidney complications
  • claustrophobia to PET/CT and SPECT
  • treatment with SGLT2 inhibitors or GLP-1 analogs.

结局指标

主要结局

Myocardium insulin resistance

Myocardium insulin resistance

次要结局

  • Coronary flow
  • Heart function

研究者

发起方
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
申办方类型
Laboratory/Research/Testing facility
责任方
Principal Investigator
主要研究者

Olga Simó Servat

Scientific

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

研究点 (1)

Loading locations...

相似试验